Provence Technologies is a founding member of AFSSI, a non-for-profit organisation gathering French companies pursuing a dual business model of services and innovations in the field of Life Sciences. In 2014, the association encompasses more than 100 active members.
Provepharm is an affiliated company of the privately-held Provence Technologies Group, devoted to develop and market the pharmaceutical grade of Methylene Blue (or Methylthioninium Chloride) Proveblue™.
Provence Technologies is a member of Eurobiomed, a non-for-profit organisation which has been accredited by the French government as a "competitive cluster". There are 71 "competitive clusters" in France and Eurobiomed is one of the eight Biotechnology - Pharma clusters.